小血小板

基本解释 (translations)

microplastocyte

与小血小板相关的网络例句 [注：此内容来源于网络，仅供参考]

Results In those patients with marrow invasion , 4 cases in I phase（4.2%）,12 cases in II phase（12.6%）,36 cases in Ⅲ phase（37.9%）and 43 cases in Ⅳ phase(47.4%);small lymphocytic、diffuse cleaved cell、lymphoblastic lymphoma are main pathologic types;patients with mediastinal lymphadenectasis、splenomegaly and spleen violations are prone to catch bone marrow involvement;56 cases of anemia in patients with bone marrow involuement(58.9%), 42 patients with thrombocytopenia (44.2%),27 cases with leukopenia (28.4%),49 cases of patients leukocyte increased (51.6%),so,anemia is common;three were 30 cases with three items abnormal（31.6％）and 65 cases with one item abnormal at least (68.4%),the incidence of abnormal peripheral blood in leukocythemia patients were higher than that in patients with bone marrow infiltration,Particularly the patients with increased leukocyte or three items abnormalities were more common in leukemia; Abnormal cells in peripheral blood were observed in 66 cases (69.5%); chemotherapy efficiency reached 65.2% in the patients with bone marrow involuement,the median survival time was 11.5 months.

结果发生骨髓侵犯病例中I期4例（4.2%）， II期12例（12.6%），Ⅲ期36例（37.9%），Ⅳ期43例(47.4%)；病理类型以小淋巴细胞性，弥漫型裂细胞性（改为：弥漫性大B细胞型淋巴瘤）和淋巴母细胞性淋巴瘤多见；纵隔淋巴结肿大、脾脏肿大和脾受侵患者易发生骨髓侵犯；骨髓侵犯患者外周血中贫血56例(58.9%)，血小板减少42例(44.2%)，白细胞减少27例(28.4%)，白细胞增高49例(51.6%)，以贫血多见；三项均异常30例(31.6%)，至少一项不正常65例(68.4%)，淋巴瘤细胞白血病患者外周血象异常发生率高于骨髓浸润患者，尤其是白细胞增高或三项均异常者更常见于白血病；66例(69.5%)外周血分类中发现异常细胞；骨髓侵犯化疗有效率65.2%，中位生存期11.5个月。

Results True positive rate: immature granulocyte, hemoglobin concentration variation, microcyte, left shift, macrocyte, hypochromic erythrocyte, large platelet, blasts, anisocytosis 86.7%-100.0%, hyperchromic erythrocyte 69.2%, nucleated red blood cell, atypical lymphocyte, platelet clumps

结果 真阳性率：未成熟粒细胞、血红蛋白浓度不等、小红细胞、核左移、大红细胞、低色素性红细胞、大血小板、原幼细胞、红细胞大小不等为86.7%~100.0%，高色素性红细胞为69.2%，有核红细胞、变异淋巴细胞、血小板凝集为13.3%~32.3%；以上所有参数真阴性率为82.8%~100.0%（平均95.0%）。

HSP is the most common blood vessel inflammation disease in childhood, its main clinical manifestations are nonthrombocyte reducing purpura, arthritis or arthralgia, bellyache, gastroenterostomy haemorrhage and nephritis, and its main pathological characteristics are general small blood vessel inflammation surrounded by neutrophils and eosinophils.

过敏性紫癜是儿童时期最常见的血管炎之一，以非血小板减少性紫癜、关节炎或关节痛、腹痛、胃肠道出血及肾炎为主要临床表现。主要病理变化为全身性小血管炎，小血管周围可见中性粒细胞及嗜酸性粒细胞浸润。

Results Erythrocyte count, hemoglobin concentration and hematocrit of all the patients with malignant digestive tumor decreased, mean corpuscular volume and mean corpuscular hemoglobin increased, arid there was inconspicuous change in total leukocyte count. The indications of megaloblastic anemia and proliferative anemia in bone marrow hemogram were found in the patients. It was common that the percentage of neutrophils was higher and that of lymphocytes was lower than that of the normal controls.

结果 消化道恶性肿瘤患者的红细胞计数、血红蛋白、红细胞压积均减少，平均红细胞体积、平均红细胞血红蛋白量增高，均表现为巨幼细胞性贫血，骨髓象呈增生性贫血改变，而白细胞总数的变化较小，白细胞分类，中性粒细胞百分比超过正常范围与淋巴细胞百分比低于正常范围者多见，血小板数异常远较血红蛋白与白细胞为少，但36例肝癌患者中28例出现血小板减少。

There is controversy as to whether prophylactic platelet transfusions are necessary or beneficial, although it seems that maintaining a platelet count of greater than 5,000, and sometimes higher, reduces the risk of minor bleeding (e.g., nose bleeds, bruises in the skin called ecchymoses, pinpoint bleeding in the skin called petechiae).

虽然把血小板计数维持在5000以上似乎能够减少小出血的风险（比如，流鼻血，皮肤的瘀斑以及小瘀点），但是人们对于预防性输注血小板的必要性及好处仍存有分歧。

There is controversy as to whether prophylactic platelet transfusions are necessary or beneficial, although it seems that maintaining a platelet count of greater than 5,000, and sometimes higher, reduces the risk of minor bleeding (e.g., nose bleeds, bruises in the skin called ecchymoses, pinpoint bleeding in the skin called petechiae).

虽然把血小板计数维持在5000以上似乎能够减少小出血的风险（比如，流鼻血，皮肤的瘀青以及小瘀点），但是人们对于预防性输注血小板的必要性及好处仍存有分歧。

There is controversy as to whether prophylactic platelet transfusions are necessary or beneficial, although it seems that maintaining a platelet count of greater than 5,000, and sometimes higher, reduces the risk of minor bleeding (e.g., nose bleeds, bruises in the skin called ecchymoses, pinpoint bleeding in the skin called petechiae).

虽然使血小板计数维持在5000以上似乎能够减少轻微出血的风险（比如，流鼻血、皮肤的瘀斑及小瘀点），但是人们对于预防性输注血小板的必要性及好处仍存有分歧。

Topotecan is an effective agent for SCLC when used as monotherapy or in combined treatment, but myelosuppression such as leucopenia and thrombopenia was relatively severe. Although it has been recommended as a second-line agent for recurrence of sensitive SCLC, more clinical trials are needed to define its role in first-line treatment.

拓扑替康治疗小细胞肺癌有确切临床疗效，无论是单药还是与其他药物的联合用药均具有与当前一线经典方案相当的疗效，但具有相对高的致白细胞和血小板下降的骨髓毒性，已被认为是治疗化疗敏感的小细胞肺癌患者复发的二线推荐药物，但是作为一线用药仍然需要更多的实践来证实。

Conclutions Topotecan is an effective remedy for treatment of small cell lung cancer, both single topotecan and combined regimen has the same effect as the traditional first-line regimen, though myelo-suppression such as leucopenia and thrombopenia is more sever, the adverse effect is tolerated. Though it has been recommended as second-line agent for chemo-therapy sensitive small cell lung cancer, there needs more clinical studies to verify its role in first-line.

结论拓扑替康是在小细胞肺癌的治疗中有确切临床疗效的药物，无论是单药还是与其他药物的联合用药均具有与当前一线经典方案相当的疗效，虽具有相对高的致白细胞和血小板下降的骨髓毒性，但毒副作用可耐受，已经被认为是治疗对化疗敏感的小细胞肺癌患者的二线推荐药物，但是作为一线用药仍然需要更多的临床证据来证实。

Results:The results of these 2 methods were(66±17)×109/L and(98 ±2 0)×109/L,their difference was significant(P＜0.001).Their influential f actors were large platelets,platelet clumps,cryoglobulins and schistocytes besid es microcytes.

结果：仪器法结果为(66±17)×109/L，而显微镜计数法为(98±20)×10 9/L，两法结果差异有显著性(P＜0.001)；URI报警时除小红细胞干扰外，还有其他诸多因素；大血小板、血小板凝集块、冷球蛋白、衰老破坏的红细胞碎片等，其中最常见的为大血小板。

与小血小板相关的网络解释 [注：此内容来源于网络，仅供参考]

anuria：无尿症

此类患者除具皮肤性局部症状外,在24小时内会出现溶血性贫血(hemolytic anaemia)、血尿(hematuria)、血红素尿(hemoglobinuria),并因红血球及血小板堆积,造成小静脉小动脉血栓,导致非发炎性肾脏病变(nephrosis)、尿少症(oliguria)或无尿症(anuria),并有30%之死亡

blood platelet：血小板

血小板(blood platelet)是哺乳动物血液中的有形成分之一. 形状不规则,比红细胞和白细胞小得多,无细胞核,有质膜,一般呈圆形,体积小于红细胞和白细胞. 导管(vessel)植物体内木质部中主要输导水分和无机盐的管状结构. 为一串高度特化的管状死细胞所组成,

osmotic fragility：渗透脆性

红细胞对低惨溶液有一定的抵抗力,其大小用渗透脆性 (osmotic fragility) 来表示. 渗透脆性小,对低渗溶液的抵抗能力大,不易发生溶血(如新生的红细胞);渗透脆性大,容易发生溶血(如衰老的红细胞). 血小板 (blood platelet) 呈双凸小盘状,

mural thrombus：附壁血栓

动脉瘤、室壁瘤内的附壁血栓(mural thrombus)及扩张的左心房内的球状血栓亦属此类. 镜下主要由淡红色无结构的不规则珊瑚状的血小板小梁和小梁间由充满红细胞的纤维素网所构成,并见血小板小梁边缘有较多的中性白细胞粘附.

platelayer''s gauge：轨距规

plated-throughhole 穿透镀膜的小孔 | platelayer's gauge 轨距规 | platelet 血小板,小片状体,片状物,凝血细胞=>血小板(PLt),プレートレット

platelet：小板

白细胞(WBC) 白细胞分类(DC) 红细胞(RBC)血色素(Hb) 血球压积(HCT) 血小板(Platelet)平均红细胞体积(MCV) 平均血红蛋白量(MCH)平均血红蛋白浓度(MCHC) 平均血小板体积测定(MPV)红细胞体积分布宽度测定(RDW)血液淋巴细胞计数(LYM

microplastocyte：小血小板

microplasticyielding 微塑性屈服 | microplastocyte 小血小板 | microplastometer 微量塑性计

microplastometer：微量塑性计

microplastocyte 小血小板 | microplastometer 微量塑性计 | microplate 微板 微板块 微型板块

platelet antibodies：小板抗体

platelet 血小板 | platelet antibodies 小板抗体 | platiculture 平皿培养

Clofibrate：氯贝丁酯

1.6 氯贝丁酯 氯贝丁酯(Clofibrate)具有降低血小板黏附的作用. 能降低血小板对ADP和ADR诱导聚集的敏感性,可延长血小板寿命,降低血浆Fib含量,防止动脉血栓形成. 用量:0.5g/次,4次/d,口服. 副作用:毒性较低,患者常能耐受,